The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis

Nephrology Dialysis Transplantation

Volumn 26, Issue 1, 2011, Pages 291-298

  Sampimon, Denise E ^a   Coester, Annemieke M ^a   Struijk, Dirk G ^a,b   Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Dianet Foundation   (Netherlands)

Author keywords

encapsulating peritoneal sclerosis; fluid kinetics; peritoneal dialysis; solute transport

Indexed keywords

DEXTRAN 70; DIALYSIS FLUID; DIANEAL; GLUCOSE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; KINETICS; LONGITUDINAL STUDY; MALE; MEMBRANE TRANSPORT; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONITIS; PRIORITY JOURNAL; RISK ASSESSMENT; TIME; TREATMENT FAILURE; ULTRAFILTRATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; PROGNOSIS; SCLEROSIS; TIME FACTORS; ULTRAFILTRATION; YOUNG ADULT;

EID: 78650668393     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq343     Document Type: Article

References (25)

1. Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM et al. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17: 136-143
2. Kawaguchi Y, Kawanishi H, Mujais S et al. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20: S43-S55
3. Kawanishi H, Moriishi M, Ide K et al. Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis. Perit Dial Int 2008; 28: S205-S210
4. Mateijsen MA, van der Wal AC, Hendriks PM et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-525
5. Afthentopoulos IE, Passadakis P, Oreopoulos DG et al. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature. Adv Ren Replace Ther 1998; 5: 157-167
6. Rottembourg J, Issad B, Langlois R et al. Loss of ultrafiltration and sclerosing encapsulating peritonitis during CAPD evaluation of the potential risk factors. Adv Perit Dial 1985; 1: 109
7. Smit W, Parikova A, Struijk DG et al. The difference in causes of early and late ultrafiltration failure in peritoneal dialysis. Perit Dial Int 2005; 25: S41-S45 (Pubitemid 40883213)
8. Mujais S, Nolph K, Gokal R et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20: S5-S21 9.
9. Davies SJ, Russell L, Bryan J et al. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 1995; 26: 353-361.
10. Pannekeet MM, Imholz AL, Struijk DG et al. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48: 866-875
11. Renck H, Ljungstrom KG, Hedin H et al. Prevention of dextran-in-duced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40. Acta Chir Scand 1983; 149: 355-360 (Pubitemid 13106703)
12. Smit W, van Dijk P, Langedijk M et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23: 440-449
13. Waniewski J, Werynski A, Heimburger O et al. Simple models for description of small-solute transport in peritoneal dialysis. Blood Purif 1991; 9: 129-141
14. Imholz AL, Koomen GC, Struijk DG et al. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 1993; 43: 1339-1346
15. Zemel D, Krediet RT, Koomen GC et al. Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 1991; 11: 217-223
16. Krediet RT, Struijk DG, Koomen GC et al. Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. ASAIO Trans 1991; 37: 662-667
17. Smit W, Struijk DG, Ho-dac-Pannekeet MM et al. Quantification of free water transport in peritoneal dialysis. Kidney Int 2004; 66: 849-854
18. Zweers MM, Imholz AL, Struijk DG et al. Correction of sodium sieving for diffusion from the circulation. Adv Perit Dial 1999; 15: 65-72
19. Imholz AL, Koomen GC, Voorn WJ et al. Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD. Nephrol Dial Transplant 1998; 13: 146-153
20. Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66: 2437-2445
21. Yaginuma T, Yamamoto I, Tanno Y et al. Peritoneal angiogenesis and lymphangiogenesis in patients with EPS. J Am Soc Nephrol 2008; 19: 474A
22. Krediet RT, Struijk DG, Boeschoten EW et al. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. Am J Kidney Dis 1989; 13: 299-307
23. Goffin E, Combet S, Jamar F et al. Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis 1999; 33: 383-388
24. Sampimon DE, Korte MR, Lopes Barreto D et al. Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int 2010; 30: 163-169
25. Cnossen TT, Smit W, Konings CJ et al. Quantification of free water transport during the peritoneal equilibration test. Perit Dial Int 2009; 29: 523-527